Literature DB >> 16403635

Cellular co-factors of HIV-1 integration.

Bénédicte Van Maele1, Katrien Busschots, Linos Vandekerckhove, Frauke Christ, Zeger Debyser.   

Abstract

To achieve productive infection, the reverse transcribed cDNA of human immunodeficiency virus type 1 (HIV-1) is inserted in the host cell genome. The main protein responsible for this reaction is the viral integrase. However, studies indicate that the virus is assisted by cellular proteins, or co-factors, to achieve integration into the infected cell. The barrier-to-autointegration factor (BAF) might prevent autointegration. Its ability to bridge DNA and the finding that the nuclear lamina-associated polypeptide-2alpha interacts with BAF suggest a role in nuclear structure organization. Integrase interactor 1 was found to directly interact with HIV-1 integrase and to activate its DNA-joining activity, and the high mobility group chromosomal protein A1 might approximate both long terminal repeat (LTR) ends and facilitate integrase binding by unwinding the LTR termini. Furthermore, the lens-epithelium-derived growth factor (LEDGF; also known as p75) seems to tether HIV-1 integrase to the chromosomes. Although a direct role in integration has only been demonstrated for LEDGF/p75, to date, each validated cellular co-factor for HIV-1 integration could constitute a promising new target for antiviral therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16403635     DOI: 10.1016/j.tibs.2005.12.002

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  75 in total

Review 1.  Allosteric inhibitor development targeting HIV-1 integrase.

Authors:  Laith Q Al-Mawsawi; Nouri Neamati
Journal:  ChemMedChem       Date:  2011-01-12       Impact factor: 3.466

2.  In vitro targeting of strand transfer by the Ty3 retroelement integrase.

Authors:  Xiaojie Qi; Suzanne Sandmeyer
Journal:  J Biol Chem       Date:  2012-04-04       Impact factor: 5.157

3.  Mechanisms and inhibition of HIV integration.

Authors:  Christophe Marchand; Allison A Johnson; Elena Semenova; Yves Pommier
Journal:  Drug Discov Today Dis Mech       Date:  2006-07-01

4.  Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication.

Authors:  Frauke Christ; Arnout Voet; Arnaud Marchand; Stefan Nicolet; Belete A Desimmie; Damien Marchand; Dorothée Bardiot; Nam Joo Van der Veken; Barbara Van Remoortel; Sergei V Strelkov; Marc De Maeyer; Patrick Chaltin; Zeger Debyser
Journal:  Nat Chem Biol       Date:  2010-05-16       Impact factor: 15.040

5.  Correlation of recombinant integrase activity and functional preintegration complex formation during acute infection by replication-defective integrase mutant human immunodeficiency virus.

Authors:  Xiang Li; Yasuhiro Koh; Alan Engelman
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

Review 6.  Integrase, LEDGF/p75 and HIV replication.

Authors:  E M Poeschla
Journal:  Cell Mol Life Sci       Date:  2008-05       Impact factor: 9.261

7.  LEDGF dominant interference proteins demonstrate prenuclear exposure of HIV-1 integrase and synergize with LEDGF depletion to destroy viral infectivity.

Authors:  Anne M Meehan; Dyana T Saenz; James Morrison; Chunling Hu; Mary Peretz; Eric M Poeschla
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

8.  Nucleocytoplasmic shuttling of HIV-1 integrase is controlled by the viral Rev protein.

Authors:  Aviad Levin; Zvi Hayouka; Assaf Friedler; Abraham Loyter
Journal:  Nucleus       Date:  2010-01-14       Impact factor: 4.197

9.  Quantitative analysis of HIV-1 preintegration complexes.

Authors:  Alan Engelman; Ilker Oztop; Nick Vandegraaff; Nidhanapati K Raghavendra
Journal:  Methods       Date:  2009-02-20       Impact factor: 3.608

Review 10.  Virological and cellular roles of the transcriptional coactivator LEDGF/p75.

Authors:  Manuel Llano; James Morrison; Eric M Poeschla
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.